Shares of Krsnaa Diagnostics rose over 5% following the announcement of strong first-quarter results for the period ending June 30, 2024. As of 9:52 AM, the shares were trading 5.57% higher at ₹677.95.
Financial Highlights
- Net Sales: ₹163.16 crore, up 23.34% from ₹132.29 crore in June 2023.
- Net Profit: ₹18.18 crore, up 19.2% from ₹15.25 crore in June 2023.
- EBITDA: ₹50.30 crore, up 38.15% from ₹36.41 crore in June 2023.
- Earnings Per Share (EPS): Increased to ₹5.63 from ₹4.86 in June 2023.
Stock Performance
- Previous Close (August 05, 2024): ₹646.45
- 6-Month Return: -11.25%
- 12-Month Return: 30.21%
Financial Summary
| Metric | June 2024 | June 2023 | Change (%) |
|---|---|---|---|
| Net Sales | ₹163.16 crore | ₹132.29 crore | 23.34% |
| Net Profit | ₹18.18 crore | ₹15.25 crore | 19.2% |
| EBITDA | ₹50.30 crore | ₹36.41 crore | 38.15% |
| EPS | ₹5.63 | ₹4.86 | – |
Krsnaa Diagnostics’ impressive financial performance in Q1 FY25 has driven positive investor sentiment, leading to a notable increase in its share price.